Difficulty: Medium
Average Score: 84%
Practice
Which neuromuscular blocking agent is contraindicated in patients with glaucoma?
Correct answer
B
Rationale
The correct answer is B) Succinylcholine. Succinylcholine is contraindicated in patients with glaucoma due to its potential to increase intraocular pressure. Glaucoma is a condition characterized by increased pressure within the eye, and the use of succinylcholine can exacerbate this condition, leading to serious complications such as vision loss.
Option A) Tubocurarine is not contraindicated in patients with glaucoma specifically. It is a non-depolarizing neuromuscular blocking agent that does not have the same impact on intraocular pressure as succinylcholine.
Option C) Pancuronium and Option D) Gallamine are also non-depolarizing neuromuscular blocking agents that do not have the same contraindication as succinylcholine in patients with glaucoma.
Educationally, understanding the contraindications of different medications is crucial for safe and effective practice, especially in advanced pharmacology. It is important for healthcare providers to be aware of the specific considerations for each medication to prevent adverse events and ensure patient safety. In the case of neuromuscular blocking agents, considering contraindications such as in glaucoma is essential to providing optimal care for patients across the lifespan.
Option A) Tubocurarine is not contraindicated in patients with glaucoma specifically. It is a non-depolarizing neuromuscular blocking agent that does not have the same impact on intraocular pressure as succinylcholine.
Option C) Pancuronium and Option D) Gallamine are also non-depolarizing neuromuscular blocking agents that do not have the same contraindication as succinylcholine in patients with glaucoma.
Educationally, understanding the contraindications of different medications is crucial for safe and effective practice, especially in advanced pharmacology. It is important for healthcare providers to be aware of the specific considerations for each medication to prevent adverse events and ensure patient safety. In the case of neuromuscular blocking agents, considering contraindications such as in glaucoma is essential to providing optimal care for patients across the lifespan.